Immunosuppressive treatment of patients with idiopathic membranous nephropathy (IMN) is debated due to its possible side effects. The 2012 KDIGO guidelines suggest alkylating agents as first choice therapy. The aim of the study is to retrospectively evaluate the induction and maintenance of clinical remission in patients with histological diagnosis of IMN undergoing steroid and/or cyclosporine therapy at the Nephrology Unit of the Sant'Andrea Hospital in Rome.
Steroid and cyclosporine therapy in idiopathic membranous nephropathy. monocentric experience and literature review / Zotta, Federica; Di Stasio, Enrico; Manzione, Andrea; Pirozzi, Nicola; Stoppacciaro, Antonella; Menè, Paolo. - In: GIORNALE ITALIANO DI NEFROLOGIA. - ISSN 1724-5990. - 36:3(2019), pp. 132-143.
Steroid and cyclosporine therapy in idiopathic membranous nephropathy. monocentric experience and literature review
Zotta, Federica;Manzione, Andrea;Pirozzi, Nicola;Stoppacciaro, Antonella;Menè, Paolo
2019
Abstract
Immunosuppressive treatment of patients with idiopathic membranous nephropathy (IMN) is debated due to its possible side effects. The 2012 KDIGO guidelines suggest alkylating agents as first choice therapy. The aim of the study is to retrospectively evaluate the induction and maintenance of clinical remission in patients with histological diagnosis of IMN undergoing steroid and/or cyclosporine therapy at the Nephrology Unit of the Sant'Andrea Hospital in Rome.| File | Dimensione | Formato | |
|---|---|---|---|
|
Zotta_Steroid.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
1.12 MB
Formato
Adobe PDF
|
1.12 MB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
